Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness.

Using innovative techniques, a new Penn Medicine study helps clear up mystery about why PARP-inhibiting compounds vary so much in their clinical effectiveness.

How do you make major life decisions knowing you are likely to develop cancer? Allison Werner-Lin looks at these questions, studying the intersection of genetics and family life.

Researchers within the Penn Pancreatic Cancer Research Center and beyond continue to seek innovative ways to treat and detect this deadly disease—and are making promising progress.

Lilith Magazine examined the genetic risk of ovarian cancer, especially in Jewish women, and interviewed Basser Executive Director Susan Domchek, MD, about prevention, screening, and treatment options.

Susan Domchek, MD, Executive Director of the Basser Center, discussed at-home genetic testing and whether or not patients who need these tests the most have access.

Cancer Today interviewed Susan Domchek, MD, Executive Director of the Basser Center, about BRCA screening, who should get tested, and who is being left out under current guidelines.

Payal D. Shah, MD, an assistant professor of Hematology-Oncology at Penn Medicine and a member of the Basser Center, spoke about new treatments that are letting people live longer and improving quality of life for some patients with metastatic breast cancer.

Experts from Penn Medicine's Abramson Cancer Center, including Basser Genetic Counselor Dana Farengo Clark, MS, LCGC, answered questions about cancer from NBC10 Philadelphia viewers as part of a telethon in partnership with the American Association for Cancer Research.

Nina Garcia, editor-in-chief of Elle Magazine and judge on Project Runway, was honored at the Basser Jean Bash fundraiser on November 18, 2019. Nina helped to launch LATINOS & BRCA, an initiative to raise awareness of hereditary cancer in the Latino community.